Market research for biotech founders and investors
RaportAgent gives biotech founders and investors a structured, sourced market study on any niche, therapeutics, diagnostics, life sciences tools and more, including FDA, EMA, clinical trial regulation, in about 30 minutes, with every key figure linked to a live source.
Why biotech founders and investors use it
- Get a sourced read on any niche within therapeutics, diagnostics, life sciences tools before committing budget or time.
- Map the competitive landscape and market size with citable figures.
- Understand the relevant regulatory context (FDA, EMA, clinical trial regulation) with source-linked citations.
- Test several niches for €19 each instead of one expensive study.
What you get
- Structured report: market size, competition, trends, sentiment, regulation, SWOT.
- Every key figure linked to a live, HTTP-checked source.
- Export to DOCX/PPTX/Markdown for decks, briefs or internal docs.
- Market Monitors to track a niche as it moves.
Explore more
Compare RaportAgent
Market research by use case
FAQ
Is this a good fit for biotech founders and investors?
Yes: describe the therapeutics niche you're looking at and the seven agents research it directly: market size, competition, trends and SWOT, with every figure linked to a live source.
Does it cover FDA-style regulation?
Yes: the regulatory section maps relevant rules and their market impact (FDA, EMA, clinical trial regulation) with source-linked citations.
How much does it cost?
€19 per report or €49 for three credits, no subscription, credit-back guarantee.
See it on your own market
Read a full sample first, then run yours, €19 per report, no subscription, credit-back guarantee.
Run your report →